A
Acumen Pharmaceuticals (ABOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD3.16
- USD3.25
- USD3.15
- USD11.31
- -21.50%
- --
- 63.52k
- 235.03k
- 190M
- 1.81
- -17.60%
Stock News
3 hours ago
Eight newspaper publishers sue OpenAI over copyright infringement
CNBC
3 hours ago
Why Crown Holdings Stock Jumped Today
Yahoo
3 hours ago
Encompass Health Corporation (NYSE:EHC) Q1 2024 Earnings Call Transcript
Yahoo
3 hours ago
Jeep, Ram parent Stellantis slides 10% as concern grows over 'bloated' inventory
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
